Resources

1 Resources for

pimavanserin

ACADIA Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript: Question-and-Answer Session Operator Operator Instructions Your first question comes from the line of William Ho - Banc Of America Securities. William Ho - Banc Of America Securities I guess, first of all, I am just wondering can you provide us or just discuss the approximate cost of completing the...; Tags: Specificity, Acadia Pharmaceuticals Inc., Call Transcript, Banc Of America Securities, Earnings, Pimavanserin, Business Structures, Financial Accounting, Finance, Seeking Alpha; Earnings calls 2008-11-05

ACADIA Pharmaceuticals, Inc. Q1 2008 Earnings Call Transcript: Question-and-Answer SessionOperator Operator Instructions. Your first question comes from the line of Jim Birchenough with Lehman Brothers. Please proceed. Jim Birchenough Hi guys, a couple of questions. I know you don’t want to provide any timelines or detail around partnership discussions. I am just wondering...; Tags: Acadia Pharmaceuticals Inc.; Earnings calls 2008-05-05
Acadia Pharmaceuticals Q3 2007 Earnings Call Transcript: Question-and-Answer SessionOperator Operator Instructions. And our first question comes from the line of Alan Carr with Needham. Go ahead. Alan Carr - Needham & Company Hi good afternoon everyone. Uli Hacksell Hi there. Alan Carr - Needham & Company Hi, yeah, sounds like you’re making some...; Tags: Acadia Pharmaceuticals Inc.; Earnings calls 2007-11-05
Acadia Offers Opportunity: Zacks.com submits: By Jason Napodano, CFA Acadia Pharmaceuticals’ ACAD stock continues to trade below cash value despite the recent positive collaboration on pimavanserin with Biovail BVF. Besides Biovail, Acadia has new relationship with the Michael J. Fox Foundation and Meiji Seika Kaisha, Ltd, as well as an...; Tags: Biotech, Zacks.com, Acadia Pharmaceuticals Inc.; External links 2009-05-13